VG · NYSE
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Total Revenue | $13.77B | $4.97B | $7.90B |
| Research & Development | $344.00M | $635.00M | $490.00M |
| Selling, General & Administrative | $433.00M | $312.00M | $224.00M |
| Operating Expenses | $8.61B | $3.21B | $3.05B |
| Operating Income | $5.16B | $1.76B | $4.85B |
| Other Income / (Expense) | -$1.79B | $420.00M | -$418.00M |
| Income Before Taxes | $3.36B | $2.18B | $4.43B |
| Provision for Income Taxes | $630.00M | $437.00M | $816.00M |
| Net Income | $2.73B | $1.75B | $3.62B |
| Basic EPS | $0.93 | $0.63 | $1.30 |
| Diluted EPS | $0.86 | $0.57 | $1.25 |
| Basic Shares Outstanding | 2.43B | 2.35B | 2.07B |
| Diluted Shares Outstanding | 2.63B | 2.58B | 2.14B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $1.51 | $1.29 | $1.77 | 9 | ↑5 ↓2 |
| Dec 2027 | $0.92 | $0.23 | $1.77 | 9 | ↑4 ↓3 |
| Dec 2028 | $0.91 | $0.19 | $1.67 | 6 | ↑4 ↓1 |
| Dec 2029 | $0.85 | $0.85 | $0.85 | 1 | ↑0 ↓0 |